Mannatech (NASDAQ:MTEX) Shares Break Below 200 Day Moving Average – Should You Sell?

Mannatech, Incorporated (NASDAQ:MTEX – Get Free Report)’s share price passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $6.35 and traded as low as $6.30. Mannatech shares last traded at $6.30, with a volume of 31,321 shares trading hands.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. Wall Street Zen raised shares of Mannatech to a “buy” rating in a research note on Saturday, November 7th. Weiss Ratings upgraded shares of Mannatech from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, October 29th. One investment analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, Mannatech presently has an average rating of “Sell”.

View Our Latest Research Report on MTEX

Mannatech Price Performance

The stock has a market cap of $12.16 million, a P/E ratio of -20.32 and a beta of 0.62. The company has a fifty day moving average price of $8.00 and a 200 day moving average price of $6.35.

Mannatech (NASDAQ:MTEX – Get Free Report) last issued its earnings results on Thursday, November 12th. The company reported $4.61 earnings per share (EPS) for the quarter. Mannatech had a negative return on equity of 2,383.34% and a negative net margin of 0.41%. The company had revenue of $24.87 million for the quarter.

Mannatech Company Profile

(Get Free Report)

Mannatech, Incorporated is a wellness company that develops and sells nutritional supplements, skincare products and other personal-care items. Its product portfolio includes supplements featuring plant-based ingredients and products marketed under brands such as Ambrotose and PhytoMatrix. The company distributes its products primarily through a network of independent sales associates, supported by online sales channels. Mannatech was founded in 1994 and serves customers in the United States and international markets.

Recommended Stories

Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.